Phenylketonuria (PKU) is caused by a deficiency of hepatic phenylalanine hydroxylase (OMIM 261600). PAH Guttler .' All mild PKU patents were on a diet with partially restricted phenylalanine intake. All the MHP patients were without dietary restrictions.
Routine screening for seven common mutations (Y414C, R408W, IVS12ntlg-a (IVS12), IVSl0nt-llg-*a (IVS10), R261Q, R252W, and R158Q) was performed as described previously.6 Then SSCP analysis of PAH exons with flanking sequences and direct sequencing (Sequenase 2.0 and ATaq) was performed.
Three novel mutations were identified in the group studied, IVS2nt5g--a (1 68+5g--a, IVS2), IVS4nt5g-.t (441+5g-->t, IVS4), and D222G (GAT-GGT). All the patients were compound heterozygotes for "severe" and "mild" mutations. The genotypic and phenotypic data obtained for the patients are summarised in table 1. In the MHP group, A403V and R297H were the most frequent "mild" mutations. Mutations A403V, A300S, and R297H were not detected in a group of 140 classical PKU patients (data not shown) or in mild PKU patients. Mutation A403V has been detected previously in southern Europe, and in Spain it is a relatively common mutation (14%).7 In the group reported here its frequency is even higher (19%), but the limited number of cases does not allow significant statistical comparison. In both countries it has been detected in combination with "severe" mutations (R408W, R252W).8 R297H has been identified in the USA with no indication of its severity.3 In the MHP group, however, it is connected with "severe" mutations, known to cause classical homozygous PKU (R408W, R252W). It is postulated that A403V and R297H could both be unambiguously ascribed to a "mild" group.
A rare mutation, F55L, was detected in a patient with MHP; it occurred with an IVS 1 Ont-1 lg-a mutation, known to produce a classical homozygous PKU phenotype.3 A patient with P89S/R408W presented a borderline MHP phenotype, with relatively high phenylalanine levels and stable high IQ scores and it is postulated that P89S is a "mild" mutation.
The next four mutations (Y414C, R243Q, R24 1 H, and Al 04D) occurred exclusively with mild PKU. The SSCP patterns indicate that these mutations are absent in a group of 140 classical PKU patients.
An A104D/D222G patient had a mild PKU phenotype with high phenylalanine tolerance (50 mg/kg/day) and normal IQ scores at the age of 2 years. Precise assessment of D222G "severity" requires identification of other patients bearing this mutation.
The novel splicing mutations (IVS2 and IVS4) were "severe" ones and when combined with mild mutations (R297H and A300S, respectively) produced a MHP phenotype.
The results presented provide preliminary data on the molecular basis of mild forms of hyperphenylalaninaemia in Poland. Identification of relatively frequent mutations connected with either MHP or mild PKU enables neonatal differential genotyping of HPA and identification of patients not requiring dietary therapy.9 "' hyperphenylalaninaemia in Poland. 
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